Research Reflection: Moving research forward during COVID-19

Christine Maheu, Manon Lemonde, Samantha Mayo, Jacqueline Galica, Jill Bally


The COVID-19 pandemic has led to major shifts in the healthcare environment, including the conduct of health research. Oncology practice has been significantly affected by abrupt measures to minimize COVID-19 exposure to cancer patients, family caregivers, and healthcare providers, such as social distancing, shifts to telehealth, redeployment and staffing changes, implementation of visitor restrictions, and round-the-clock use of personal protective equipment (Duncan et al., 2021). Efforts to minimize the risk of COVID-19 transmission also resulted in significant reductions in enrolling cancer patients in clinical trials in the early stages of the pandemic, especially for non-interventional studies (Tolaney et al., 2020; Waterhouse et al., 2020). 

Full Text:



Avis, N. E., Smith, K. W., Link, C. L., Hortobagyi, G. N., & Rivera, E. (2006). Factors associated with participation in breast cancer treatment clinical trials. Journal of Clinical Oncology, 24(12), 1860–1867.

Borno, H. T., Zhang, L., Siegel, A., Chang, E., & Ryan, C. J. (2018). At what cost to clinical trial enrollment? A retrospective study of patient travel burden in cancer clinical trials. The Oncologist, 23(10), 1242–1249.

Duncan, R., Szabo, B., Jackson, Q. L., Crain, M., Lett, C., Masters, C., Spinks, R., Uhrig, L. K., & Gullatte, M. M. (2021). Care and coping during COVID-19: Practice changes and innovations in the oncology setting. Clinical Journal of Oncology Nursing, 25(1), 48–55.

Hamel, L. M., Penner, L. A., Albrecht, T. L., Heath, E., Gwede, C. K., & Eggly, S. (2016). Barriers to clinical trial enrollment in racial and ethnic minority patients with cancer. Cancer Control, 23(4), 327–337.

Sedrak, M. S., Freedman, R. A., Cohen, H. J., Muss, H. B., Jatoi, A., Klepin, H. D., Wildes, T. M., Le-Rademacher, J. G., Kimmick, G. G., Tew, W. P., George, K., Padam, S., Liu, J., Wong, A. R., Lynch, A., Djulbegovic, B., Mohile, S. G., Dale, W., & Cancer and Aging Research Group (CARG). (2021). Older adult participation in cancer clinical trials: A systematic review of barriers and interventions. CA: A Cancer Journal for Clinicians, 71(1), 78–92.

Sellars, B. B., Sherrod, D. R., & Chappel-Aiken, L. (2018). Using word clouds to analyze qualitative data in clinical settings. Nursing Management, 49(10), 51–53.

Tolaney, S. M., Lydon, C. A., Li, T., Dai, J., Standring, A., Legor, K. A., Caparrotta, C. M., Schenker, M. P., Glazer, D. I., Tayob, N., DuBois, S. G., Meyerhardt, J. A., Taplin, M.-E., & Johnson, B. E. (2020). The impact of COVID-19 on clinical trial execution at the Dana-Farber Cancer Institute. Journal of the National Cancer Institute.

Waterhouse, D. M., Harvey, R. D., Hurley, P., Levit, L. A., Kim, E. S., Klepin, H. D., Mileham, K. F., Nowakowski, G., Schenkel, C., Davis, C., Bruinooge, S. S., & Schilsky, R. L. (2020). Early impact of COVID-19 on the conduct of oncology clinical trials and long-term opportunities for transformation: Findings from an American Society of Clinical Oncology Survey. JCO Oncology Practice, 16(7), 417–421.

Zanville, N., Cohen, B., Gray, T. F., Phillips, J., Linder, L., Starkweather, A., Yeager, K. A., & Cooley, M. E. (2021). The Oncology Nursing Society rapid review and research priorities for cancer care in the context of COVID-19. Oncology Nursing Forum, 48(2), 131–145.


  • There are currently no refbacks.